BIONOMICS LIMITED (A public company limited by shares organized under the laws of the Commonwealth of Australia) 641,026 American Depositary SharesUnderwriting Agreement • October 18th, 2023 • Bionomics Limited/Fi • Pharmaceutical preparations • New York
Contract Type FiledOctober 18th, 2023 Company Industry JurisdictionBionomics Limited, a public company incorporated under the laws of the Commonwealth of Australia (the “Company”), confirms its agreement with Aegis Capital Corp. (“Aegis”), Berenberg Capital Markets LLC (“Berenberg”) and the other Underwriter named in Schedule A hereto (collectively, the “Underwriters,” which term shall also include any underwriter substituted as hereinafter provided in Section 11 hereof), for whom Aegis, the lead underwriter, and Berenberg, joint book running manager, are acting as representatives (in such capacity, the “Representatives”), with respect to (i) the sale by the Company and the purchase by the Underwriters, acting
Controlled Equity OfferingSM Sales AgreementSales Agreement • October 18th, 2023 • Bionomics Limited/Fi • Pharmaceutical preparations • New York
Contract Type FiledOctober 18th, 2023 Company Industry JurisdictionBionomics Limited, a public company incorporated under the laws of the Commonwealth of Australia (the “Company”), confirms its agreement (this “Agreement”) with Cantor Fitzgerald & Co. (the “Agent”), as follows:
COMMERCIAL IN CONFIDENCEConsultancy Agreement • October 18th, 2023 • Bionomics Limited/Fi • Pharmaceutical preparations
Contract Type FiledOctober 18th, 2023 Company Industry
BIONOMICS LIMITED CONNOR B. BERNSTEIN, JB STRATEGY PARTNERS LLC consultancy agreement Exh. 4.21-1Consultancy Agreement • October 18th, 2023 • Bionomics Limited/Fi • Pharmaceutical preparations
Contract Type FiledOctober 18th, 2023 Company Industry
CONSULTING AGREEMENTConsulting Agreement • October 18th, 2023 • Bionomics Limited/Fi • Pharmaceutical preparations • Massachusetts
Contract Type FiledOctober 18th, 2023 Company Industry JurisdictionThis Consulting Agreement (the “Agreement”) is made effective as of July 16, 2021 (the “Effective Date”), by and between Bionomics Limited, an Australian corporation, with its principal place of business being 31 Dalgleish Street, Thebarton SA 5031 AUSTRALIA (the “Company”) and Danforth Advisors, LLC, a Massachusetts limited liability company, with its principal place of business being 91 Middle Road, Southborough, MA 01772 (“Danforth”). The Company and Danforth are herein sometimes referred to individually as a “Party” and collectively as the “Parties.”
EMPLOYMENT AGREEMENTEmployment Agreement • October 18th, 2023 • Bionomics Limited/Fi • Pharmaceutical preparations • Massachusetts
Contract Type FiledOctober 18th, 2023 Company Industry JurisdictionTHIS EMPLOYMENT AGREEMENT (this “Agreement”) is entered into effective as of the Effective Date (as defined below), by and between Bionomics Inc., a Delaware corporation (the “Company”), a subsidiary of Bionomics Limited (the “Parent”), and Spyridon “Spyros” Papapetropoulos (“Executive”).